Trifecta™ GT Post Market Clinical Follow-up
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 358 participants.
Also called NCT03016169
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 358 participants
- Sponsor
- Registry
-
NCT03016169
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, Estonia, France, Germany, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03016169. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-09 (actual); primary completion 2023-04-25 (actual). Results posted on 2024-05-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trifecta™ GT Post Market Clinical Follow-up
- Condition
- Aortic Valve Disease
- Condition
- Aortic Valve Disorder
- Intervention (Device)
- Trifecta GT (Glide Technology) Valve
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03016169- Content hash
9e9b23c773c243f17d4a3e400cbc35b17dad52f7aff81cc3f0534397192b5df8